United States

Showing 111-120 of 328 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Anti-Serpin B13 Hu-mAb Lead Candidate Developability Assessment	Mosaic Biosciences, Inc.	Malavi Madireddi	Cures	01-June-2025 to 01-April-2026	$293,674.00
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare	Nemours Children's Clinic	Jessica Pierce	Improving Lives	01-May-2023 to 30-April-2026	$628,819.87
Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D	Neurodon LLC	Russell Dahl	Cures	01-June-2022 to 31-May-2026	$920,000.00
GPR75, a novel actor in beta cell regeneration	New York Medical College	Ercument Dirice	Cures	01-April-2022 to 31-March-2026	$750,000.00
Engineering hypoimmune cells for Type 1 Diabetes	New York Stem Cell Foundation, Inc.	Daniel Paull	Cures	01-May-2025 to 30-April-2028	$1,498,415.83
A New Preparation of the Intact Eye for Measurements of Retinal Dysfunction in Acute Hyperglycemia and Early Diabetes	Northwestern University	Gregory Schwartz	Improving Lives	01-October-2023 to 30-September-2026	$406,927.40
Assessment of a Tolerogenic Nanoparticle in a Humanized Mouse Islet Transplantation Model	Northwestern University	Jacqueline Burke	Cures	01-April-2024 to 31-March-2026	$499,746.76
Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model	Northwestern University	Jacqueline Burke	Cures	01-July-2023 to 30-June-2026	$998,275.64
PLGA nanoparticle treatment-induced antigen-specific CD4+ regulatory T cell control of effector CD8+ T cell responses in a model of type 1 diabetes	Northwestern University	Stephen Miller	Cures	01-September-2025 to 31-August-2028	$659,990.00
Development of an AI-informed Bayesian decision support system for optimizing benefit in islet transplant therapy	Oregon State University	Peter Jacobs	Cures	01-June-2025 to 31-May-2028	$749,999.83